![Angela Lamarca: We MUST validate innovate biomarkers in clinical trials](https://oncodaily.com/pub/uploads/2024/06/download-83-e1719420708943.jpg)
Photo of Angela Lamarca from X
Jul 4, 2024, 12:15
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“Last session of the day on Precision Medicine in European Network for the Study of Cholangiocarcinoma (ENS-CCA), Precision-BTC-Network joint meeting in Krakow.
- surgical candidates
- neoadjuvant
- chemoresistance?
- markers for IO
- new markers- circRNAs
We MUST validate innovate biomarkers in clinical trials.”
Source: Angela Lamarca/X
Angela Lamarca
biomarkers
cancer
Chemoresistance
cholangiocarcinoma
circRNAs
clinical trials
ENS-CCA
European Network for the Study of Cholangiocarcinoma
HPB Oncologist
immunotherapy
Jimenez Diaz Foundation
neoadjuvant therapy
NET Oncologist
OncoDaily
Oncology
Precision Medicine
Precision-BTC-Network
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023